期刊文献+

APC基因异常甲基化在上皮性卵巢癌中的检测及临床意义 被引量:2

Hypermethylation of APC Gene Promoter in Epithelial Ovarian Carcinoma
下载PDF
导出
摘要 目的观察结肠腺瘤性息肉病(APC)基因异常甲基化在上皮性卵巢癌中的作用及临床意义。方法59例上皮性卵巢癌组织原发灶,32例相应的盆、腹腔转移灶,12例癌旁卵巢组织及30例正常卵巢组织,采用甲基化特异性聚合酶链式反应(MSP)法检测APC基因启动子区甲基化状态。结果上皮性卵巢癌组织原发灶及相应的盆、腹腔转移灶中存在APC基因启动子区异常甲基化,发生率分别为32.2%、40.6%,显著高于正常卵巢组织(P<0.01)。12例癌旁卵巢组织中1例检测到APC基因启动子区甲基化,30例正常卵巢组织未检测到。APC基因启动子区甲基化的发生率在临床Ⅰ、Ⅱ期低于Ⅲ、Ⅳ期(P<0.05),在高分化癌中低于低分化癌(P<0.05)。结论APC基因启动子区异常甲基化与上皮性卵巢癌发生密切相关,并可能与上皮性卵巢癌临床分期及分化程度有关。 Objective To observe the role of promoter hypermethylation of adenomatous polypesis coli (APC) gene in the course of epithelial ovarian carcinoma. Methods Hypermethylation of APC promoter was detected by methylation specific PCP (MSP) in 59 epithelial ovarian cancer primary tissues, 32 metastatic tissues of pelvic and abdomen cavity, 12 adjacent non-cancerous ovarian tissues and 30 normal ovarian tissues. Results Hypermethylation of APC promoter was detected in ovarian cancer tissues and metastatic sites, the frequency being 32.2% and 40.6% respectively, which was significantly higher than that in normal ovarian tissues( P 〈 0.01 ). Hypennethylation of APC promoter was detected in 1 out of 12 adjacent ovarian tissues, and no hypermethylation was detected in normal ovarian tissues. The frequency of hypermethylatiou of APC promoter was significantly lower in cancers of stage Ⅰ and Ⅱthan that in stage Ⅲ and Ⅳ ( P 〈 0.05), and so was that in well differentiated cancers than that in poorly differentiated ones. Conclusion Promoter hypermethylation of APC plays an important role in the course of epithelial ovarian carcinoma, and it is related to clinical stage and histopathological grade in epithelial ovarian carcinoma.
出处 《白求恩军医学院学报》 2008年第5期257-259,F0002,共4页 Journal of Bethune Military Medical College
关键词 卵巢癌 APC基因 DNA甲基化 Ovarian careinoma APC gene DNA hypermethylation
  • 相关文献

参考文献9

  • 1[1]Yang Y,Takenchi S,Tsukai K,et al.Methylatinn analysis of the adenomatons polyposis coli(APC) C,ene in adult T-cell leukemia/lymphoma.Leuk Res,2005,29(1):47-51.
  • 2[2]Zysrnan M,Saka A,MiUar A,et al.Methylation of adetenomatous polyposis coli in endmetrial carcinoma occurs more frequently in tumors with microsatellite instability phenotype.Carcinoma Res,2002,62(13):3663-3666.
  • 3[3]Zambrano P,Segura-PachecoB,Perez-Cardlenas E,et al.A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes.BMC C.aneer,2005,5(1):44.
  • 4[4]Wiley A,Katsaros D,Chert H,et al.Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian turnors with lowmalignant potential.Cancer,2006,107(2):299-308.
  • 5[5]Makarla PB,Saboorian MH,Ashfaq R,et al.Promorer hypermethylation profile of ovarian epithelial neoplasrns.Clin Cancer Res,2005,11 (15):5365-5369.
  • 6[6]Lustig B,Behrens J.The signaling pathway and its role in tumor development.J Cancer Res Clin Oncol,2003,129(4):199-221.
  • 7[7]Hatle KM,Neven W,Dienz O,et al.Methylation-controlled J protein promotes c-Jun degradation to Prevent ABCBI transporter expression.Mol Cell Biol,2007,27(8):2952-2966.
  • 8[8]Collins Y,Dicinccio R,Keitz B,et al.Methylation of death-associated protein kinase in ovarian carcinomas.Int J Gynecol Cancer,2006,16[Suppl I]:195-199.
  • 9[9]Wei SH,Balch C,Paik HH,et al.Prognostic DNA methylation biomarkers in ovarian cancer.Clin Cancer Res,2006,12(9):2788-2794.

同被引文献17

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部